A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) with Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3)

Full Title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Mevrometostat (PF-06821497) with Enzalutamide in Metastatic Castration-Sensitive Prostate Cancer (MEVPRO-3) (Advarra IRB)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

DFor more information or to see if you can join this study, please call Dr. Dana Rathkopf’s office at 646-422-4379.